AFib Patients Face Higher Risks with Antiplatelet Therapy
You may be at a higher risk for bleeding if you add antiplatelet drugs to anticoagulant therapy.
Atrial fibrillation (AFib) is usually treated with anticoagulant medications such as warfarin (Coumadin). AFib is the uncoordinated beating of the heartís upper chambers (atria), which allows blood to pool in the heart. The result can be a blood clot that could leave the heart and eventually cause a stroke.